Introduction {#sec1}
============

Hydrohalogenation of a multiple bond is a fundamental approach for the synthesis of halogenated compounds. Although the carbon--carbon double bonds of alkenes undergo electrophilic addition of hydrogen halides to afford alkyl halides, the carbon--carbon triple bonds of alkynes cannot undergo similar reactions efficiently,^[@ref1],[@ref2]^ primarily because of the lower stability of the cationic intermediate derived from the electronegative sp carbon as compared with that from an sp^2^ carbon. Moreover, the produced haloalkene exhibits a higher reactivity when compared with the starting alkyne and undergoes a second hydrohalogenation reaction.^[@ref3]^ To avoid this undesired second reaction, metal catalysts or reagents other than hydrohalic acids are often used.^[@ref4]^ On the other hand, alkynes undergo nucleophilic addition fairly easily to yield substituted alkenes; however, the addition of hydrogen halides initiated by the nucleophilic attack of a halide ion has not been reported to date because of the low nucleophilicity.

To this end, we focused on 2-ethynylpyridine **1**, which has both a basic ring nitrogen and an electrophilic ethynyl group ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}), as it was considered to be a suitable substrate for hydrohalogenation via nucleophilic addition. In other words, the nitrogen of **1** forms a pyridinium salt **3** upon treatment with hydrohalic acid **2**, which enhances the electrophilicity of the ethynyl group. Furthermore, the spatial proximity between the ethynyl group and the counteranion facilitates the nucleophilic addition to afford 2-(2-haloethenyl)pyridine **4**.

![Reaction Design of Hydrohalogenation of 2-Ethynylpyridine **1**](ao-2017-00133t_0001){#sch1}

The 2-(2-haloethenyl)pyridine framework is often found in biologically active compounds^[@ref5]^ and is also used as a synthetic intermediate for the synthesis of versatile compounds.^[@ref6]^ Despite their high utility, only a few methods are available for the preparation of ethenylpyridines. Specifically, Guinchard et al. synthesized 2-(2-chloroethenyl)pyridine by the cross-coupling reaction of potassium(2-chloroethenyl)trifluoroborates with 2-bromopyridine.^[@ref7]^ Wittig bromoolefination of pyridinecarbaldehyde leading to the synthesis of 2-(2-bromoethenyl)pyridine was also reported by Kaloko and Hayford.^[@ref8]^ However, these approaches suffer from the poor availability of the starting materials and low reaction efficiencies. There is no report regarding the preparation of **4** upon addition of hydrogen halide **2** to **1**, except for a single description,^[@ref9]^ which prompted us to study this reaction.

Results and Discussion {#sec2}
======================

When a suspension of pyridinium salt **3Aa**, derived from **1A** (R = Ph) and hydrochloric acid **2a**, was heated in benzene at 100 °C for 14 h, a small amount of 2-(2-chloro-2-phenylethenyl)pyridine hydrochloride (**5Aa**) was detected as a single isomer ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). The regio- and stereochemistries of the product were confirmed using X-ray crystallography for the hydrobrominated product **5Ab** ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entry 1). Ethenylpyridine **4Aa** was readily liberated upon treatment of **5Aa** with an equimolar amount of triethylamine. Among the several tested solvents, aprotic polar solvents such as tetrahydrofuran (THF) and acetonitrile were found to be effective; however, the yield was rather poor when methanol was used ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 2--4). Although acetonitrile afforded the best result, the yield of **5Aa** was still 50%, and 50% of **1A** was recovered by the proton transfer from **3Aa** to the more basic ethenylpyridine **4Aa** formed in situ (entry 4). Hence, the reaction was conducted in the presence of additional 1 equiv of **2a**. Although the reaction did not proceed at room temperature, heating at higher than 60 °C resulted in hydrochlorination (entries 5--7). Heating at 100 °C could shorten the reaction time, and all **3Aa** was consumed within 14 h to afford **5Aa** in 82% yield (entry 8--10). Even though large amounts of hydrochloric acid were used, the second hydrohalogenation was not observed because the sp^2^ carbon of **5Aa** is less electrophilic than the sp carbon of **3Aa** (entry 11).

###### Optimization of the Reaction Conditions for the Hydrochlorination of **1A**

![](ao-2017-00133t_0007){#GRAPHIC-d7e304-autogenerated}

  entry   *x*   solv.   temp (°C)   time (h)   yield (%)   recovery (%)
  ------- ----- ------- ----------- ---------- ----------- -----------------------------------
  1       0     PhH     100         14         7           90
  2       0     THF     100         14         27          0
  3       0     MeOH    100         14         10          61
  4       0     MeCN    100         14         50          0[a](#t1fn1){ref-type="table-fn"}
  5       1     MeCN    rt          24         0           quant.
  6       1     MeCN    60          24         20          66
  7       1     MeCN    80          24         51          22
  8       1     MeCN    100         3          16          71
  9       1     MeCN    100         8          51          22
  10      1     MeCN    100         14         82          0
  11      10    MeCN    100         14         84          0

50% of **1A** was recovered.

Several alkynes were used for this reaction under optimized conditions ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Diphenylacetylene (**6A**) and 2-(phenylethynyl)nitrobenzene (**6B**) caused no change (entries 1 and 2). These results indicate that the 2-pyridyl group is crucial for this reaction, as the pyridine ring serves not only as an electron-withdrawing group but also as a base to attract hydrogen chloride by forming pyridinium salt **3**.

###### Study on the Ring Nitrogen and Position of the Ethynyl Group

![](ao-2017-00133t_0008){#GRAPHIC-d7e528-autogenerated}

      alkyne                                 
  --- ---------- --- -------- --------- ---- -----
  1   CH             **6A**   **9Aa**   0    100
  2   C--NO~2~       **6B**   **9Ba**   0    100
  3   N          3   **7**    **10**    0    100
  4   N          4   **8**    **11**    22   78

Ethynylpyridines **7** and **8**, positional isomers of **1A**, revealed different reactivities. 3-Ethynylpyridine **7** was inert and was recovered quantitatively (entry 3). On the other hand, 4-ethynylpyridine **8** underwent hydrochlorination, although the reaction efficiency was low (entry 4). Although the nitrogen activates the ethynyl group by an electron-withdrawing resonance effect, the distance cannot diminish the electron density of the ethynyl group because of the lack of electron-withdrawing inductive effects. Thus, the distance between the basic site and the reaction sites is also important for the hydrochlorination. In other words, the chloride anion attacks the ethynyl group intramolecularly rather than intermolecularly. Indeed, the reaction of **3Aa** afforded **5Aa** in a similar yield, even though the reaction mixture was diluted from 0.5 to 0.05 M.

Next, other hydrohalic acids **2b**--**d** were subjected to the reaction ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Hydrobromic acid **2b** and hydroiodic acid **2c** underwent the reaction smoothly to give 2-(bromoethenyl)pyridine **5Ab** and 2-(iodoethenyl)pyridine **5Ac** in excellent yields (entries 1 and 2). Although hydrofluoric acid **2d** formed pyridinium salt **3Ad**, the subsequent addition reaction did not proceed, presumably because of the low nucleophilicity of the fluoride anion (entry 3). Sulfonic acids **2e** and **2f** and trifluoroacetic acid **2g** exhibited similar reactivities and afforded salts **3Ae**, **3Af**, and **3Ag**, respectively (entries 4--6). On the other hand, the less acidic carboxylic acids **2h** and **2i** could not form pyridinium acetate **3Ah** and **3Ai** (entries 7 and 8). The issue was resolved by anion exchange using silver acetate. When 2-(phenylethynyl)pyridinium chloride (**3Aa**) and 2 equiv of silver acetate were heated at 120 °C in acetonitrile, hydroacetoxylated product **4Ai** was obtained, albeit in a low yield, and considerable amounts of **1A** were obtained owing to the deprotonation of **3Aa** by the more basic acetate anion ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref10]^ Although the formation of **4Ai** was confirmed using ^1^H NMR and high-resolution mass spectrometry (HRMS), it could not be isolated using column chromatography because it hydrolyzed to form phenacylpyridine, the hydrated form of **1A**, on silica gel. However, all attempts to exchange the chloride ion of **3Aa** with the other halide ion using tetrabutylammonium fluoride, cesium fluoride, potassium bromide, and potassium iodide failed under the same reaction conditions.

![Hydroacetoxylation of Ethynylpyridine **1A**](ao-2017-00133t_0002){#sch2}

###### Reactions of **1A** with Other Acids

![](ao-2017-00133t_0009){#GRAPHIC-d7e763-autogenerated}

  entry                               HX                    product   yield (%)
  ----------------------------------- ------------ -------- --------- -----------
  1                                   HBr          **2b**   **5Ab**   70
  2[a](#t3fn1){ref-type="table-fn"}   HI           **2c**   **5Ac**   97
  3                                   HF           **2d**   **5Ad**   0
  4                                   MeSO~3~H     **2e**   **5Ae**   0
  5                                   PhSO~3~H     **2f**   **5Af**   0
  6                                   CF~3~COOH    **2g**   **5Ag**   0
  7                                   *t*-BuCOOH   **2h**   **5Ah**   0
  8                                   AcOH         **2i**   **5Ai**   0

At 60 °C.

Several ethynylpyridine hydrochlorides **3Ba**--**3Oa** were used to expand the scope of substrates ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). Hydrochlorides of ethynylpyridines **3Ba**--**3Da**, having an electron-donating or an electron-withdrawing group on the benzene ring, underwent the desired reaction to afford the corresponding chloroethenylpyridines **5Ba**--**5Da** (entries 1--3). The ethynyl group is not required to have an aryl group, as hexynylpyridine **3E** furnished the hydrochlorinated product **5Ea** in high yield (entry 4). Although a bulky *tert*-butyl group diminished the reaction efficiency, the hydrochlorinated product **5Fa** was obtained in a high yield at a higher reaction temperature (entry 5). Substrates **3G**--**I**, possessing functional groups such as trimethylsilyl, methoxycarbonyl, or a hydroxymethyl, afforded the corresponding products **5Ga**--**5Ia** in moderate to excellent yields, highlighting the functional group tolerance of the reaction under the employed conditions (entries 6--8). This reaction was applicable to terminal alkyne **3J**, leading to the formation of **5Ja** (entry 9). Because olefinic protons have a coupling constant of 13.6 Hz, the *E*-form might be formed to avoid the steric repulsion between a chloro and a pyridyl group. In cases of substrates possessing an electron-withdrawing group, a small amount of inseparable isomer was also formed (entries 3, 7, and 12). Although the structure of the minor isomer has not been determined, it is considered to be a regioisomer of **5** because the electron density at the α-carbon of the pyridine moiety is also diminished.

###### Hydrochlorination of Other Ethynylpyridines

![](ao-2017-00133t_0010){#GRAPHIC-d7e975-autogenerated}

  entry                                R^1^              R^2^                product            yield (%)
  ------------------------------------ ----------------- --------- --------- ------------------ -----------
  1                                    4-EtOC~6~H~4~     H         **3Ba**   **5Ba**            69
  2                                    4-BuC~6~H~4~      H         **3Ca**   **5Ca**            86
  3                                    4-CF~3~C~6~H~4~   H         **3Da**   **5Da**            59
  4                                    Bu                H         **3Ea**   **5Ea**            84
  5[a](#t4fn1){ref-type="table-fn"}    *t*-Bu            H         **3Fa**   **5Fa**            89
  6                                    Me~3~Si           H         **3Ga**   **5Ga**            40
  7                                    MeOCO             H         **3Ha**   **5Ha**            46
  8[b](#t4fn2){ref-type="table-fn"}    HOCH~2~           H         **3Ia**   **5Ia**([@ref9])   80
  9                                    H                 H         **3Ja**   **5Ja**            44
  10[c](#t4fn3){ref-type="table-fn"}   Ph                4-Me      **3Ka**   **5Ka**            15
  11[c](#t4fn3){ref-type="table-fn"}   Ph                3-Me      **3La**   **5La**            80
  12[b](#t4fn2){ref-type="table-fn"}   Ph                4-CN      **3Ma**   **5Ma**            60
  13                                   Ph                3-Br      **3Na**   **5Na**            63
  14                                   Ph                3-C≡CPh   **3Oa**   **5Oa**            77

At 150 °C for 5 h.

At 65 °C for 14 h.

At 150 °C for 3 h.

Next, substituent effects of the pyridine ring were studied because electron-donating groups increase the basicity of the ring nitrogen and electron-withdrawing groups diminish the electron density of the ethynyl group.^[@ref11]^ In the case of **3Ka**, the reaction was suppressed, and severe conditions were required because stabilization of the pyridinium cation by the electron-donating group, especially in the case of **3Ka**, could not diminish the electron density of the ethynyl group sufficiently (entries 10 and 11, [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). On the other hand, electron-withdrawing groups promoted the reactivity for hydrochlorination to afford the corresponding products **5Ma** and **5Na** in moderate yields (entries 12 and 13). Hence, the activation of the ethynyl group was found to be an influential factor. When 2,3-bis(phenylethynyl)pyridinium salt **3Oa** was used as a substrate, only the ethynyl group at the 2-position was hydrochlorinated without any reaction on the ethynyl group at the 3-position (entry 14).

![Resonance Structures of the Protonated **3Ja**](ao-2017-00133t_0003){#sch3}

Furthermore, this protocol was applicable to other ethynylated azaheterocycles **12** ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}). Although ethynylquinoline **12a** and ethynylisoquinoline **12d** underwent the hydrohalogenation to afford the corresponding haloalkenes **13a**--**d** in high yields, 8-ethynylquinoline **12e** afforded a complex mixture because the ethynyl group was not activated by the resonance effects of the ring nitrogen. Pyrimidine **12f** and benzimidazole **12g** also underwent the reaction efficiently to afford the corresponding haloalkenes **13f** and **13g**, respectively.

###### Hydrohalogenation of Other Ethynylated Azaheterocycles

![](ao-2017-00133t_0011){#gr7}

The obtained 2-(2-bromoethenyl)pyridine **4Ab** was subjected to the Suzuki coupling. Both electron-rich and electron-poor boronic acids underwent the cross-coupling reactions to afford triarylated alkenes **14h**--**j** in high yields ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).^[@ref12]^

![Synthesis of Triarylated Alkenes **14**](ao-2017-00133t_0004){#sch4}

Haloalkene **4Eb** was a viable substrate for Sonogashira coupling, affording corresponding enynes **15k** and **15l** ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}).^[@ref8],[@ref13]^ On the other hand, when trimethylsilylacetylene was used as a coupling partner, enyne **15m** was not obtained, and desilylation occurred under the employed conditions. Instead, 3,3′-bis(indolizine) **16** was isolated as a result of double coupling and tandem cyclization ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}).^[@ref14]^ Modification of the 3,3′-positions of the bis(indolizine) framework was easily achieved by changing the starting 2-(bromoethenyl)pyridines **4**.

![Synthesis of Enynes **15**](ao-2017-00133t_0005){#sch5}

![Synthesis of 3,3′-Bis(indolizine)s **16**](ao-2017-00133t_0006){#sch6}

Conclusions {#sec3}
===========

We established a nucleophilic hydrohalogenation protocol using ethynylpyridines containing a basic nitrogen and electrophilic ethynyl group. The initial salt formation is crucial to attract a halide ion and facilitate the nucleophilic addition to the ethynyl group. Each hydrohalogenation afforded single stereoisomer, which is presumably a *Z* form, although regioisomers were obtained in some cases. The obtained 2-(haloethenyl)pyridines serve as substrates for cross-coupling reactions to afford triarylalkenes and enynes, which will be useful scaffolds for the development of new functional materials.

Experimental Section {#sec4}
====================

General Procedure for Hydrohalogenation {#sec4-1}
---------------------------------------

To a solution of 2-phenylethynylpyridine **1A** (0.5 mmol, 89.5 mg) in MeCN (10 mL), 12 M HCl (0.5 mmol, 0.042 mL) was added at room temperature, and the mixture was stirred for 10 min. Then, the mixture was heated at 100 °C for 14 h in a sealed tube. Triethylamine (0.5 mmol, 0.07 mL) was added, and the mixture was extracted with CHCl~3~ (10 mL × 3), dried over MgSO~4~, filtered, and concentrated. Purification was achieved using flash column chromatography on silica gel to afford 2-(2-chloro-2-phenylethenyl)pyridine **4Aa** (94 mg, 82%, 0.41 mmol eluted with hexane/ethyl acetate = 9/1) as yellow oil.

When other substrates were used, reactions were performed in a similar way.

### 2-(2-Chloro-2-phenylethenyl)pyridine (**4Aa**) {#sec4-1-1}

^1^H NMR (400 MHz, CDCl~3~): δ 8.67 (ddd, *J* = 4.8, 1.8, 0.9 Hz, 1H), 8.06 (ddd, *J* = 7.7, 1.1, 0.9 Hz, 1H), 7.74 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.76--7.73 (m, 2H), 7.40 (s, 1H), 7.44--7.37 (m, 3H), 7.22 (ddd, *J* = 7.7, 4.8, 1.1 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 122.3 (CH), 124.1 (CH), 126.7 (CH), 126.9 (CH), 128.4 (CH), 129.2 (CH), 134.8 (C), 136.0 (CH), 138.7 (C), 149.5 (CH), 154.4 (C); IR (ATR, cm^--1^): 1620; HRMS (ESI/TOF): calcd for (M + H^+^) C~13~H~12~ClN, 216.0575; found, 216.0575.

### 2-(2-Bromo-2-phenylethenyl)pyridine (**4Ab**) {#sec4-1-2}

Yellow oil (91 mg, 70%, 0.35 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.66 (ddd, *J* = 4.8, 1.8, 0.9 Hz, 1H), 8.11 (ddd, *J* = 7.7, 1.1, 0.9 Hz, 1H), 7.71--7.69 (m, 2H), 7.68 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.42--7.35 (m, 3H), 7.39 (s, 1H), 7.20 (ddd, *J* = 7.7, 4.8, 1.1 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 122.4 (CH), 123.9 (CH), 126.6 (C), 127.9 (CH), 128.4 (CH), 129.2 (CH), 130.3 (CH), 135.9 (CH), 140.6 (C), 149.5 (CH), 155.1 (C); IR (ATR, cm^--1^): 1581; HRMS (ESI/TOF): calcd for (M + H^+^) C~13~H~11~BrN~2~, 260.0069; found, 260.0081.

### 2-(2-Iodo-2-phenylethenyl)pyridine (**4Ac**) {#sec4-1-3}

Yellowish green oil (149 mg, 97%, 0.485 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.71 (ddd, *J* = 4.8, 1.8, 0.9 Hz, 1H), 7.91 (ddd, *J* = 7.7, 1.1, 0.9 Hz, 1H), 7.87 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.62--7.60 (m, 2H), 7.39--7.33 (m, 3H), 7.36 (ddd, *J* = 7.7, 4.8, 1.1 Hz, 1H), 7.26 (s, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 105.2 (C), 122.7 (CH), 123.9 (CH), 128.3 (CH), 128.7 (CH), 128.9 (CH), 136.1 (CH), 136.7 (CH), 144.1 (C), 149.3 (CH), 156.4 (C); IR (ATR, cm^--1^): 1584; HRMS (ESI/TOF): calcd for (M + H^+^) C~13~H~11~IN~2~, 307.9931; found, 307.9942.

### 2-\[2-Chloro-4-(ethoxyphenyl)ethenyl\]pyridine (**4Ba**) {#sec4-1-4}

Yellow oil (90 mg, 69%, 0.345 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.63 (ddd, *J* = 5.6, 1.7, 0.7 Hz, 1H), 8.09 (d, *J* = 7.7 Hz, 1H), 7.71 (ddd, *J* = 1.7, 7.7, 7.7 Hz, 1H), 7.68 (d, *J* = 8.1 Hz, 2H), 7.25 (s, 1H), 7.16 (ddd, *J* = 0.7, 5.6, 7.7 Hz, 1H), 6.91 (d, *J* = 8.1 Hz, 2H), 4.07 (q, *J* = 7.0 Hz, 2H), 1.42 (t, *J* = 7.0 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 14.7 (CH~3~), 63.5 (CH~2~), 114.3 (CH), 122.0 (CH), 123.9 (CH), 124.9 (CH), 128.2 (CH), 130.5 (C), 130.9 (C), 135.9 (CH), 149.4 (CH), 154.6 (C), 159.9 (C); IR (ATR, cm^--1^): 1604; HRMS (ESI/TOF): calcd for (M + H^+^) C~15~H~15~ClNO, 260.0836; found, 260.0817.

### 2-\[2-(4-Butylphenyl)-2-chloroethenyl\]pyridine (**4Ca**) {#sec4-1-5}

Colorless oil (102 mg, 86%, 0.43 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.64 (ddd, *J* = 4.9, 1.8, 1.0 Hz, 1H), 8.11 (d, *J* = 7.8 Hz, 1H), 7.73 (ddd, *J* = 7.8, 7.8, 1.8 Hz, 1H), 7.66 (d, *J* = 8.3 Hz, 2H), 7.24 (d, *J* = 8.3 Hz, 2H), 7.20 (s, 1H), 7.18 (ddd, *J* = 7.8, 4.9, 1.0 Hz, 1H), 2.64 (t, *J* = 7.6 Hz, 2H), 1.62 (tt, *J* = 7.6, 7.4 Hz, 2H), 1.37 (tq, *J* = 7.6, 7.4 Hz, 2H), 0.94 (q, *J* = 7.4 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 13.9 (CH~3~), 22.3 (CH~2~), 33.4 (CH~2~), 35.3 (CH~2~), 122.2 (CH), 124.0 (C), 125.9 (CH), 126.8 (CH), 128.5 (CH), 134.9 (CH), 135.9 (C), 136.0 (CH), 144.4 (C), 149.5 (CH), 154.5 (C); IR (ATR, cm^--1^): 1633; HRMS (ESI/TOF): calcd for (M + H^+^) C~17~H~19~ClN, 272.1200; found, 272.1199.

### 2-\[2-Chloro-4-(trifluoromethylphenyl)ethenyl\]pyridine (**4Da**) {#sec4-1-6}

Brown oil \[82 mg, 59%, 0.295 mmol, a mixture of regioisomers (93/7)\]. Major isomer: ^1^H NMR (400 MHz, CDCl~3~): δ 8.64 (ddd, *J* = 8.0, 5.6, 1.0 Hz, 1H), 8.12 (d, *J* = 8.0 Hz, 1H), 7.86 (d, *J* = 8.0 Hz, 2H), 7.77 (ddd, *J* = 8.0, 8.0, 1.6 Hz, 1H), 7.67 (d, *J* = 8.0 Hz, 2H), 7.36 (s, 1H), 7.24 (ddd, *J* = 5.6, 1.6, 0.8 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 122.8 (CH), 124.3 (CH), 125.4 (C), 125.5 (C, q, *J* = 3.7 Hz), 127.2 (CH), 128.5 (CH), 133.1 (C), 136.0 (CH), 142.0 (C), 149.6 (CH), 153.7 (C); IR (ATR, cm^--1^): 1614; HRMS (ESI/TOF): calcd for (M + H^+^) C~14~H~10~F~3~ClN, 284.0448; found, 284.0445.

### 2-(2-Chloro-1-hexen-1-yl)pyridine (**4Ea**) {#sec4-1-7}

Brown oil (82 mg, 84%, 0.42 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.58 (ddd, *J* = 4.8, 1.8, 0.9 Hz, 1H), 7.67 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.49 (ddd, *J* = 7.7, 1.1, 0.9 Hz, 1H), 7.14 (ddd, *J* = 7.7, 4.8, 1.1 Hz, 1H), 2.53 (t, *J* = 7.0 Hz, 2H), 1.67 (tt, *J* = 7.0, 7.0 Hz, 2H), 1.40 (tq, *J* = 7.0, 7.0 Hz, 2H), 0.95 (q, *J* = 7.0 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 13.9 (CH~3~), 21.6 (CH~2~), 30.4 (CH~2~), 43.2 (CH~2~), 122.1 (CH), 123.6 (CH), 128.2 (CH), 130.7 (C), 135.9 (CH), 149.2 (CH), 155.0 (C); IR (ATR, cm^--1^): 1651; HRMS (ESI/TOF): calcd for (M + H^+^) C~17~H~19~ClN, 196.0888; found, 196.0891.

### 2-(2-Chloro-3,3-dimethyl-1-buten-1-yl)pyridine (**4Fa**) {#sec4-1-8}

Brown oil (89 mg, 84%, 0.42 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.57 (ddd, *J* = 4.8, 1.8, 0.9 Hz, 1H), 7.90 (ddd, *J* = 7.7, 1.1, 0.9 Hz, 1H), 7.66 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.14 (ddd, *J* = 7.7, 4.8, 1.1 Hz, 1H), 6.73 (s, 1H), 1.33 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~): δ 28.9 (CH~3~), 39.8 (C), 121.8 (CH), 122.6 (CH), 124.2 (CH), 135.8 (CH), 147.8 (C), 149.2 (CH), 154.9 (C); IR (ATR, cm^--1^): 1631; HRMS (ESI/TOF): calcd for (M + H^+^) C~11~H~15~ClN, 196.0888; found, 196.0893.

### 2-\[2-Chloro-2-(trimethylsilyl)ethenyl\]pyridine (**4Ga**) {#sec4-1-9}

Brown oil (43 mg, 40% yield, 0.20 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.62 (ddd, *J* = 4.8, 1.8, 0.9 Hz, 1H), 8.13 (ddd, *J* = 7.7, 1.1, 0.9 Hz, 1H), 7.71 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.19 (ddd, *J* = 7.7, 4.8, 1.1 Hz, 1H), 7.08 (s, 1H), 0.29 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~): δ −0.004 (CH~3~), 124.8 (CH), 126.7 (CH), 138.4 (CH), 138.6 (CH), 143.5 (C), 151.7 (CH), 156.4 (C); IR (ATR, cm^--1^): 1581; HRMS (ESI/TOF): calcd for (M + H^+^) C~10~H~15~ClNSi, 212.0657; found, 212.0666.

### Methyl 2-Chloro-3-(2-pyridyl)propenoate (**4Ha**) {#sec4-1-10}

Colorless oil \[37 mg, 46% yield, 0.23 mmol, a mixture of regioisomers (90/10)\]. Major isomer: ^1^H NMR (400 MHz, CDCl~3~): δ 8.62 (ddd, *J* = 4.8, 1.8, 0.9 Hz, 1H), 7.95 (ddd, *J* = 7.7, 1.1, 0.9 Hz, 1H), 7.80 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.50 (s, 1H), 7.34 (ddd, *J* = 7.7, 4.8, 1.1 Hz, 1H), 3.83 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 51.8 (CH~3~), 118.0 (CH), 122.2 (CH), 124.8 (CH), 137.2 (CH), 143.2 (C), 149.3 (CH), 152.6 (C), 164.9 (C); IR (ATR, cm^--1^): 1625, 1728; HRMS (ESI/TOF): calcd for (M + H^+^) C~9~H~19~ClNO~2~, 198.0316; found, 198.0321.

### 2-(2-Chloro-2-hydroxy-1-propen-1-yl)pyridine (**5Ia**)^[@ref9]^ {#sec4-1-11}

Brown oil (77 mg, 80%, 0.4 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.56 (ddd, *J* = 8.0, 4.2, 1.8 Hz, 1H), 7.97 (d, *J* = 8.0 Hz, 1H), 7.72 (ddd, *J* = 8.0, 8.0, 1.8 Hz, 1H), 7.20 (ddd, *J* = 8.0, 4.2, 1.8 Hz, 1H), 7.16 (s, 1H), 5.30 (br s, 1H), 4.36 (s, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ 66.5 (CH~2~), 122.5 (CH), 123.2 (CH), 124.1 (CH), 136.6 (CH), 137.5 (C), 140.8 (CH), 153.6 (C).

### 2-(2-Chloroethenyl)pyridine (**4Ja**) {#sec4-1-12}

Pale yellow oil (25 mg, 44%, 0.22 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.53 (dd, *J* = 4.2, 1.0 Hz, 1H), 7.63 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.23 (d, *J* = 13.6 Hz, 1H), 7.14--7.17 (m, 2H), 6.86 (d, *J* = 13.6 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 121.7 (CH), 122.6 (CH), 124.3 (CH), 132.6 (CH), 136.7 (CH), 149.7 (CH), 153.4 (C); IR (ATR, cm^--1^): 1616; HRMS (ESI/TOF): calcd for (M + H^+^) C~7~H~7~ClN, 140.02615; found, 140.02557.

### 2-(2-Chloro-2-phenylethenyl)-4-methylpyridine (**4Ka**) {#sec4-1-13}

Colorless oil (18 mg, 15%, 0.075 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.47 (d, *J* = 4.9 Hz, 1H), 8.04 (s, 1H), 7.83 (d, *J* = 7.5 Hz, 2H), 7.70 (s, 1H), 7.41 (dd, *J* = 7.5, 7.5 Hz, 2H), 7.33 (t, *J* = 7.5 Hz, 1H), 7.07 (d, *J* = 4.9 Hz, 1H), 2.42 (CH~3~); ^13^C NMR (100 MHz, CDCl~3~): δ 21.2 (CH~3~), 121.9 (CH), 123.9 (CH), 128.0 (CH), 128.2 (CH), 128.3 (CH), 129.9 (CH), 130.1 (C), 134.9 (C), 148.2 (C), 148.8 (CH), 154.6 (C); IR (ATR, cm^--1^): 1641; HRMS (ESI/TOF): calcd for (M + H^+^) C~14~H~13~ClN, 230.0731; found, 230.0742.

### 2-(2-Chloro-2-phenylethenyl)-3-methylpyridine (**4La**) {#sec4-1-14}

Brown oil (93 mg, 80%, 0.40 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.56 (dd, *J* = 7.7, 4.8 Hz, 1H), 7.76--7.73 (m, 2H), 7.55 (dd, *J* = 7.7, 4.8 Hz, 1H), 7.43--7.38 (m, 3H), 7.19 (s, 1H), 7.17 (dd, *J* = 7.7, 4.8 Hz, 1H), 2.35 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 18.8 (CH~3~), 122.6 (CH), 124.6 (CH), 126.9 (CH), 127.9 (CH), 128.8 (CH), 129.2 (CH), 136.7 (CH), 137.9 (CH), 138.2 (CH), 146.6 (C), 153.7 (CH); IR (ATR, cm^--1^): 1620; HRMS (ESI/TOF): calcd for (M + H^+^) C~14~H~13~ClN, 230.0731; found, 230.0743.

### 2-(2-Chloro-2-phenylethenyl)-4-cyanopyridine (**4Ma**) {#sec4-1-15}

Brown oil \[73 mg, 60%, 0.3 mmol, a mixture of regioisomers (89/11)\]. Major isomer: ^1^H NMR (400 MHz, CDCl~3~): δ 8.82 (dd, *J* = 5.0, 0.8 Hz, 1H), 8.37 (s, 1H), 7.76--7.74 (m, 2H), 7.45--7.41 (m, 3H), 7.43 (dd, *J* = 5.0, 0.8 Hz, 1H), 7.28 (s, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 116.6 (C), 120.6 (C), 123.3 (CH), 124.9 (CH), 125.5 (CH), 126.9 (CH), 128.6 (CH), 129.9 (CH), 137.5 (C), 137.9 (C), 150.4 (CH), 155.7 (C); IR (ATR, cm^--1^): 1587, 2237; HRMS (ESI/TOF): calcd for (M + H^+^) C~14~H~10~ClN~2~, 241.0527; found, 241.0536.

### 3-Bromo-2-(2-chloro-2-phenylethenyl)pyridine (**4Na**) {#sec4-1-16}

Brown oil (93 mg, 63%, 0.315 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.65 (dd, *J* = 4.6, 1.4 Hz, 1H), 7.91 (dd, *J* = 8.1, 1.4 Hz, 1H), 7.77--7.75 (m, 2H), 7.43--7.40 (m, 3H), 7.31 (s, 1H), 7.11 (dd, *J* = 8.1, 4.6 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 121.9 (C), 123.6 (CH), 123.9 (CH), 127.1 (CH), 128.5 (CH), 129.5 (CH), 137.8 (C), 138.3 (C), 140.2 (CH), 147.8 (CH), 153.4 (C); IR (ATR, cm^--1^): 1607; HRMS (ESI/TOF): calcd for (M + H^+^) C~13~H~11~ClNBr, 293.9680; found, 293.9686.

### 2-(2-Chloro-2-phenylethenyl)-3-phenylethynylpyridine (**4Oa**) {#sec4-1-17}

Yellow oil (123 mg, 77%, 0.39 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.67 (dd, *J* = 1.6, 4.8 Hz, 1H), 7.85 (dd, *J* = 1.6, 7.9 Hz, 1H), 7.79 (dd, *J* = 1.9, 8.2 Hz, 2H), 7.61 (s, 1H), 7.50--7.47 (m, 2H), 7.44--7.38 (m, 3H), 7.37--7.32 (m, 3H), 7.22 (dd, *J* = 4.8, 7.9 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 85.7 (C), 96.8 (C), 120.4 (C), 121.8 (CH), 122.6 (C), 123.6 (CH), 127.1 (CH), 128.5 (CH), 128.9 (CH), 129.3 (CH), 131.6 (CH), 137.1 (C), 138.9 (C), 139.4 (CH), 148.1 (CH), 155.6 (C); IR (ATR, cm^--1^): 1620, 2214; HRMS (ESI/TOF): calcd for (M + H^+^) C~21~H~16~ClN, 316.0888; found, 316.0879.

### 2-(2-Chloro-2-phenylethenyl)quinoline (**13a**) {#sec4-1-18}

Yellow oil (85 mg, 64%, 0.32 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.23--8.07 (m, 2H), 8.08 (d, *J* = 8.5 Hz, 1H), 7.82--7.79 (m, 3H), 7.71 (ddd, *J* = 6.9, 6.9, 1.4 Hz, 1H), 7.53 (ddd, *J* = 8.0, 8.0, 1.0 Hz, 1H), 7.47 (s, 1H), 7.44--7.38 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 121.8 (CH), 126.8 (CH), 126.9 (CH), 127.1 (CH), 127.2 (C), 127.5 (CH), 128.5 (CH), 129.3 (CH), 129.4 (CH), 129.7 (CH), 135.8 (CH), 136.0 (C), 138.6 (C), 148.1 (C), 154.8 (C); IR (ATR, cm^--1^): 1606; HRMS (ESI/TOF): calcd for (M + H^+^) C~17~H~13~ClN, 266.0731; found, 266.0740.

### 2-(2-Bromo-2-phenylethenyl)quinoline (**13b**) {#sec4-1-19}

Yellow oil (158 mg, 89%, 0.445 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.20--8.08 (m, 3H), 7.82 (d, *J* = 8.1 Hz, 1H), 7.77--7.74 (m, 2H), 7.71 (ddd, *J* = 1.4, 6.8, 6.8 Hz, 1H), 7.59 (s, 1H), 7.54 (ddd, *J* = 1.4, 6.8, 6.8 Hz, 1H), 7.43--7.37 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 121.7 (CH), 126.8 (CH), 127.2 (C), 127.5 (CH), 127.7 (CH), 127.8 (C), 127.9 (CH), 129.3 (CH), 129.5 (CH), 129.7 (CH), 130.7 (CH), 135.8 (CH), 140.4 (C), 148.0 (C), 155.5 (C); IR (ATR, cm^--1^): 1593; HRMS (ESI/TOF): calcd for (M + H^+^) C~17~H~13~BrN, 310.0226; found, 310.0233.

### 2-(2-Iodo-2-phenylethenyl)quinoline (**13c**) {#sec4-1-20}

Yellow oil (174 mg, 97%, 0.49 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.20 (d, *J* = 8.5 Hz, 1H), 8.13 (d, *J* = 8.5 Hz, 1H), 7.87 (d, *J* = 8.5 Hz, 1H), 7.84 (dd, *J* = 1.0, 8.5 Hz, 1H), 7.73 (ddd, *J* = 1.5, 6.9, 6.9 Hz, 1H), 7.68--7.66 (m, 2H), 7.56 (ddd, *J* = 1.0, 6.9, 6.9 Hz, 1H), 7.39--7.33 (m, 4H); ^13^C NMR (400 MHz, CDCl~3~): δ 106.5 (C), 121.8 (CH), 126.8 (CH), 127.3 (C), 127.6 (CH), 128.3 (CH), 128.8 (CH), 129.0 (CH), 129.3 (CH), 129.8 (CH), 135.9 (CH), 136.9 (CH), 143.9 (C), 147.8 (C), 156.7 (C); IR (ATR, cm^--1^): 1591; HRMS (ESI/TOF): calcd for (M + H^+^) C~17~H~13~IN, 358.0087; found, 358.0089.

### 1-(2-Chloro-2-phenylethenyl)isoquinoline (**13d**) {#sec4-1-21}

Yellow oil (67 mg, 52%, 0.26 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.62 (d, *J* = 5.7 Hz, 1H), 8.10 (dd, *J* = 0.9, 8.4 Hz, 1H), 7.85--7.82 (m, 3H), 7.68 (ddd, *J* = 1.2, 6.8, 6.8 Hz, 1H), 7.62 (d, *J* = 5.7 Hz, 1H), 7.59 (s, 1H), 7.57 (ddd, *J* = 1.2, 6.8, 6.8 Hz, 1H), 7.46--7.39 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 120.4 (CH), 123.5 (CH), 126.2 (CH), 126.9 (CH), 127.1 (C), 127.4 (CH), 128.5 (CH), 129.5 (CH), 130.2 (CH), 136.3 (C), 137.9 (C), 138.0 (C), 142.3 (CH), 155.4 (C); IR (ATR, cm^--1^): 1625; HRMS (ESI/TOF): calcd for (M + H^+^) C~17~H~13~ClN, 266.0731; found, 266.0719.

### 2-(2-Chloro-2-phenylethenyl)pyrimidine (**13f**) {#sec4-1-22}

Yellow oil (57 mg, 50%, 0.25 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.82 (d, *J* = 4.8 Hz, 2H), 7.79--7.71 (m, 2H), 7.44--7.40 (m, 3H), 7.39 (s, 1H), 7.15 (t, *J* = 4.8 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 118.7 (CH), 125.0 (CH), 127.2 (CH), 128.5 (CH), 129.7 (CH), 138.6 (C), 139.2 (C), 156.8 (CH), 163.7 (C); IR (ATR, cm^--1^): 1622; HRMS (ESI/TOF): calcd for (M + H^+^) C~12~H~10~ClN~2~, 217.0527; found, 217.0527.

### 2-(2-Chloro-2-phenylethenyl)-1-methylbenzimidazole (**13g**) {#sec4-1-23}

Brown solid (93 mg, 69%, 0.35 mmol). mp 145--146 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 7.86--7.83 (m, 1H), 7.76--7.74 (m, 2H), 7.43--7.31 (m, 3H), 7.31--7.27 (m, 3H), 7.07 (s, 1H), 3.75 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 30.4 (CH~3~), 109.3 (CH), 113.4 (CH), 120.2 (CH), 122.5 (CH), 123.2 (CH), 127.0 (CH), 128.7 (CH), 129.9 (CH), 135.2 (C), 137.8 (C), 140.7 (C), 143.2 (C), 148.4 (C); IR (ATR, cm^--1^): 1634; HRMS (ESI/TOF): calcd for (M + H^+^) C~16~H~14~ClN~2~, 269.0840; found, 269.0838.

Hydroacetoxylation {#sec4-2}
------------------

To a solution of 2-(phenylethynyl)pyridinium chloride (0.5 mmol, 115 mg) in MeCN (10 mL), silver acetate (1.0 mmol, 167 mg) was added. After heating the resultant mixture at 120 °C for 6 h in a sealed tube, the solvent was removed under reduced pressure to afford the reaction mixture as a residue.

The formation of hydroacetoxylated product **4Ai** was confirmed using ^1^H NMR, GC--MS, and HRMS spectra of the reaction mixture. However, the product could not be isolated because of the instability in the silica gel column chromatography.

HRMS (ESI/TOF): calcd for (M + H^+^) C~15~H~14~NO~2~, 240.1020; found, 240.1021.

Suzuki--Miyaura Coupling Reaction Using Hydrobrominated Product **4Ab** {#sec4-3}
-----------------------------------------------------------------------

To a solution of 2-(2-bromo-2-phenylethenyl)pyridine **4Ab** (2 mmol, 518 mg) in THF (10 mL) were added 4-chlorophenylboronic acid (3 mmol, 470 mg), CsCO~3~ (3 mmol, 977 mg), PPh~3~ (0.4 mmol, 105 mg), and Pd(OAc)~2~ (0.2 mmol, 45 mg) under argon. After being stirred at 60 °C for 1 day, the mixture was then poured into H~2~O (30 mL) and extracted with EtOAc (30 mL × 2). The organic layer was dried over MgSO~4~, filtered, and concentrated and subjected to flash chromatography on silica gel to afford coupling product **14h** (497 mg, 57%, and 1.14 mmol eluted with hexane/EtOAc = 9/1) as yellow solid.

When other boronic acids were used, reactions were conducted in a similar way.

### 2-\[2-(4-Chlorophenyl)-2-phenylethenyl\]pyridine (**14h**) {#sec4-3-1}

^1^H NMR (400 MHz, CDCl~3~): δ 8.50 (ddd, *J* = 4.8, 1.8, 0.9 Hz, 1H), 7.36--7.29 (m, 9H), 7.13 (d, *J* = 8.2 Hz, 2H), 7.00 (ddd, *J* = 8.4, 4.8, 0.9 Hz, 1H), 6.75 (d, *J* = 8.0 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ 121.4 (CH), 123.8 (CH), 127.8 (CH), 128.2 (CH), 128.4 (C), 129.1 (CH), 130.0 (CH), 131.7 (CH), 133.7 (C), 135.5 (CH), 142.2 (C), 144.6 (C), 149.4 (CH), 156.3 (C); IR (ATR, cm^--1^): 1581; HRMS (ESI/TOF): calcd for (M + H^+^) C~19~H~15~ClN, 292.0888; found, 292.0890.

### 2-\[2-(4-Methoxylphenyl)-2-phenylethenyl\]pyridine (**14i**)^[@cit12a]^ {#sec4-3-2}

Yellow oil (645 mg, 75%, 1.50 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 8.53 (ddd, *J* = 5.0, 1.9, 0.9 Hz, 1H), 7.39--7.29 (m, 6H), 7.16--7.08 (m, 3H), 7.04--6.96 (m, 1H), 6.92--6.85 (m, 2H), 6.76 (d, *J* = 7.8 Hz, 1H), 3.83 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 55.3 (CH~3~), 114.0 (CH), 121.0 (CH), 123.7 (CH), 127.8 (CH), 128.0 (CH), 128.1 (CH), 131.3 (CH), 131.9 (C), 135.3 (CH), 142.7 (C), 145.6 (C), 149.0 (CH), 156.7 (C), 159.1 (C).

### 2-\[2-(4-Methylphenyl)-2-phenylethenyl\]pyridine (**14j**)^[@cit12a]^ {#sec4-3-3}

^1^H NMR (400 MHz, CDCl~3~): δ 8.53 (ddd, *J* = 5.0, 1.9, 0.9 Hz, 1H), 7.39--7.29 (m, 6H), 7.16--7.08 (m, 3H), 7.04--6.96 (m, 1H), 6.92--6.85 (m, 2H), 6.76 (d, *J* = 7.8 Hz, 1H), 3.83 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 21.2 (CH~3~), 121.0 (CH), 123.6 (CH), 127.7 (CH), 127.9 (CH), 128.1 (CH), 128.4 (CH), 129.4 (CH), 129.9 (CH), 135.2 (CH), 136.8 (C), 137.4 (C), 142.7 (C), 149.1 (CH), 156.7 (C).

Sonogashira Coupling Reaction Using Hydrobrominated Product **4Eb** {#sec4-4}
-------------------------------------------------------------------

To a solution of bromoethenylpyridine **4Eb** (0.2 mmol, 47.8 mg) in NEt~3~ (1 mL) were added PdCl~2~(PPh~3~)~2~ (0.02 mmol, 14 mg) and CuI (0.2 mmol, 38 mg) under argon. After adding 1-hexyne (0.4 mmol, 0.044 mL) dropwise, the resultant mixture was stirred at room temperature for 1 day. The reaction mixture was filtered using Celite (10 g) with washing with CH~2~Cl~2~ (10 mL). After the filtrate was concentrated, the residue was subjected to flash chromatography on silica gel to give enyne **15k** (28.4 mg, 59%, 0.118 mmol, eluted with hexane/EtOAc = 9/1) as brown oil.

When 4-methylphenylacetylene was used as a coupling partner, the reaction was conducted in a similar way.

### 2-(2-Bromo-1-hexene-1-yl)pyridine (**4Eb**) {#sec4-4-1}

^1^H NMR (400 MHz, CDCl~3~): δ 8.59 (dd, *J* = 4.4, 1.6 Hz, 1H), 7.92 (d, *J* = 7.6 Hz, 1H), 7.68 (ddd, *J* = 7.6, 7.6, 1.6 Hz, 1H), 7.16 (dd, *J* = 7.6, 4.4 Hz, 1H), 6.92 (s, 1H), 2.66 (t, *J* = 7.2 Hz, 2H), 1.67 (tt, *J* = 7.2, 7.6 Hz, 2H), 1.37 (tq, *J* = 7.6, 7.2 Hz, 2H), 0.95 (t, *J* = 7.6 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 13.8 (CH~3~), 21.6 (CH~2~), 30.4 (CH~2~), 43.2 (CH~2~), 122.1 (CH), 123.6 (CH), 128.3 (CH), 130.6 (C), 135.8 (CH), 149.3 (CH), 155.0 (C); IR (ATR, cm^--1^): 1622; HRMS (ESI/TOF): calcd for (M + H^+^) C~11~H~15~BrN, 240.0382; found, 240.0385.

### 2-(2-Butyl-1-octene-3-yne-1-yl)pyridine (**15k**) {#sec4-4-2}

^1^H NMR (400 MHz, CDCl~3~): δ 9.22 (dd, *J* = 5.4, 1.5 Hz, 1H), 7.86 (ddd, *J* = 7.7, 7.7, 1.8 Hz, 1H), 7.35 (ddd, *J* = 7.7, 5.4, 1.3 Hz, 1H), 7.30 (d, *J* = 7.7 Hz, 1H), 6.62 (s, 1H), 2.94 (t, *J* = 7.1 Hz, 2H), 2.56 (t, *J* = 7.1 Hz, 2H), 1.66 (tt, *J* = 7.7, 7.2 Hz, 2H), 1.79 (tt, *J* = 7.7, 7.2 Hz, 2H), 1.59--1.36 (m, 4H), 0.96 (t, *J* = 7.3 Hz, 6H); ^13^C NMR (100 MHz, CDCl~3~): δ 13.6 (CH~3~), 13.8 (CH~3~), 22.0 (CH~2~), 22.1 (CH~2~), 24.7 (CH~2~), 30.9 (CH~2~), 31.1 (CH~2~), 39.1 (CH~2~), 110.8 (C), 123.2 (CH), 126.6 (CH), 126.8 (C), 129.8 (CH), 138.6 (CH), 151.1 (CH), 151.3 (C); IR (ATR, cm^--1^): 1634, 2328; HRMS (ESI/TOF): calcd for (M + H^+^) C~17~H~24~N, 242.1903; found, 242.1904.

### 2-\[2-(4-Methylphenyl)-hex-1-ene-1-yl\]pyridine (**15l**) {#sec4-4-3}

Brown solid (35 mg, 62%, 0.124 mmol). mp 105--106 °C. ^1^H NMR (400 MHz, CDCl~3~): δ 9.34 (d, *J* = 4.7 Hz, 1H), 7.89 (d, *J* = 8.0 Hz, 2H), 7.85--8.00 (m, 1H), 7.35--7.40 (m, 2H), 7.24 (d, *J* = 8.0 Hz, 1H), 6.69 (s, 1H), 2.44 (t, *J* = 7.6 Hz, 2H), 2.39 (s, 3H), 1.76 (tt, *J* = 7.6, 7.4 Hz, 2H), 1.45 (tq, *J* = 7.4, 7.3 Hz, 2H), 0.97 (t, *J* = 7.3 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 13.9 (CH~3~), 21.6 (CH~3~), 22.1 (CH~2~), 31.1 (CH~2~), 38.9 (CH~2~), 109.3 (C), 120.1 (C), 123.1 (CH), 126.3 (C), 127.1 (CH), 129.5 (CH), 133.3 (CH), 138.7 (CH), 140.5 (C), 151.3 (CH); IR (ATR, cm^--1^): 1643; HRMS (ESI/TOF): calcd for (M + H^+^) C~20~H~22~N, 276.1747; found, 276.1746.

Synthesis of Bis(indolizine) {#sec4-5}
----------------------------

To a solution of bromoethenylpyridine **4Eb** (0.2 mmol, 48 mg) in NEt~3~ (1 mL) were added PdCl~2~(PPh~3~)~2~ (0.02 mmol, 14 mg) and CuI (0.2 mmol, 38 mg) under argon. After adding (trimethylsilyl)acetylene (0.4 mmol, 0.056 mL) dropwise, the resultant mixture was stirred at room temperature for 1 day. The reaction mixture was filtered using Celite (10 g) with washing with CH~2~Cl~2~ (10 mL). After the filtrate was concentrated, the residue was subjected to flash chromatography on silica gel to give enyne **16n** (13 mg, 58%, 0.058 mmol, eluted with hexane/EtOAc = 8/2) as blue oil.

When other enynes were used, the experiments were conducted in a similar way.

### 3,3′-Bis(indolizine) (**16n**)^[@ref13]^ {#sec4-5-1}

^1^H NMR (400 MHz, CDCl~3~): δ 9.34 (d, *J* = 4.7 Hz, 1H), 7.89 (d, *J* = 8.0 Hz, 2H), 7.85--7.90 (m, 1H), 7.35--7.40 (m, 2H), 7.24 (d, *J* = 8.0 Hz, 1H), 6.69 (s, 1H), 2.44 (t, *J* = 7.6 Hz, 2H), 2.39 (s, 3H), 1.76 (tt, *J* = 7.6, 7.4 Hz, 2H), 1.45 (tq, *J* = 7.4, 7.3 Hz, 2H), 0.97 (t, *J* = 7.3 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 13.9 (CH~3~), 21.6 (CH~3~), 22.1 (CH~2~), 31.1 (CH~2~), 38.9 (CH~2~), 92.6 (C), 109.3 (C), 120.1 (C), 123.1 (CH), 126.3 (C), 127.1 (CH), 129.5 (CH), 133.3 (CH), 138.7 (CH), 140.5 (C), 151.3 (CH).

### 2,2′-Dibutyl-3,3′-bis(indolizine) (**16o**) {#sec4-5-2}

Blue oil (69 mg, quant., 0.10 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 7.34 (dd, *J* = 8.9, 0.9 Hz, 2H), 7.20 (dd, *J* = 6.4, 0.9 Hz, 2H), 6.69 (ddd, *J* = 0.9, 6.4, 8.9 Hz, 2H), 6.47 (s, 2H), 6.34 (ddd, *J* = 0.9, 7.0, 7.0 Hz, 2H), 2.46 (q, *J* = 7.8 Hz, 4H), 1.53 (tt, *J* = 7.8, 7.4 Hz, 4H), 1.25 (tq, *J* = 7.8, 7.4 Hz, 4H), 0.79 (t, *J* = 7.4 Hz, 6H); ^13^C NMR (100 MHz, CDCl~3~): δ 13.8 (CH~3~), 22.5 (CH~2~), 26.4 (CH~2~), 32.9 (CH~2~), 98.8 (CH), 109.6 (CH), 111.6 (C), 117.3 (CH), 118.4 (CH), 122.9 (CH), 132.5 (C), 133.6 (C); IR (ATR, cm^--1^): 1620; HRMS (ESI/TOF): calcd for (M + H^+^) C~24~H~31~N~2~, 345.2325; found, 345.2315.

### 2,2′-Diphenyl-3,3′-bis(indolizine) (**16p**)^[@ref15]^ {#sec4-5-3}

Blue oil (15 mg, 39%, 0.039 mmol). ^1^H NMR (400 MHz, CDCl~3~): δ 7.43 (d, *J* = 8.9 Hz, 2H), 7.30--7.27 (m, 6H), 7.16--7.07 (m, 6H), 6.90 (s, 2H), 6.70 (ddd, *J* = 8.9, 6.5, 0.9 Hz, 2H), 6.27 (ddd, *J* = 6.5, 6.5, 0.9 Hz, 2H); ^13^C NMR (100 MHZ, CDCl~3~): δ 98.5 (CH), 110.5 (C), 110.6 (CH), 118.5 (CH), 118.7 (CH), 123.0 (CH), 126.5 (C), 126.7 (CH), 128.5 (CH), 130.5 (C), 134.0 (C), 135.3 (C).

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b00133](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b00133).Copies of ^1^H and ^13^C NMR spectra and crystal data of **3Aa** and **5Ab** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00133/suppl_file/ao7b00133_si_001.pdf))X-ray crystallographic data for **3Aa** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00133/suppl_file/ao7b00133_si_002.cif))X-ray crystallographic data for **5Ab** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00133/suppl_file/ao7b00133_si_003.cif))
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